Allarity Therapeutics, Inc.
ALLR
$1.61
-$0.15-8.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.81M | 1.63M | 5.47M | 1.59M | 2.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -798.00K | -- | -- |
| Total Operating Expenses | 4.13M | 3.04M | 7.32M | 2.61M | 3.37M |
| Operating Income | -4.13M | -3.04M | -7.32M | -2.61M | -3.37M |
| Income Before Tax | -2.32M | -2.73M | -7.45M | -11.97M | -1.63M |
| Income Tax Expenses | -- | -- | 0.00 | -377.00K | -- |
| Earnings from Continuing Operations | -2.32M | -2.73M | -7.45M | -11.59M | -1.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.32M | -2.73M | -7.45M | -11.59M | -1.63M |
| EBIT | -4.13M | -3.04M | -7.32M | -2.61M | -3.37M |
| EBITDA | -4.12M | -3.03M | -7.32M | -2.61M | -3.37M |
| EPS Basic | -0.15 | -0.25 | -1.72 | -7.71 | -3.34 |
| Normalized Basic EPS | -0.09 | -0.15 | -1.08 | -0.90 | -2.04 |
| EPS Diluted | -0.15 | -0.25 | -1.72 | -7.71 | -3.34 |
| Normalized Diluted EPS | -0.09 | -0.15 | -1.08 | -0.90 | -2.04 |
| Average Basic Shares Outstanding | 15.54M | 11.15M | 4.33M | 1.58M | 499.30K |
| Average Diluted Shares Outstanding | 15.54M | 11.15M | 4.33M | 1.58M | 499.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |